Nano-X (NNOX) marketing chief details option and share holdings
Rhea-AI Filing Summary
Nano-X Imaging Ltd. executive Aharon Cohen Tamar, EVP & Chief Marketing Officer, reported his initial equity holdings. He directly holds ordinary shares, including 39,474 ordinary shares, and has 20,000 ordinary shares tied to restricted share units granted on February 5, 2026, which vest 50% after 12 months and 50% after 24 months.
He also holds stock options over ordinary shares: 33,000 at an exercise price of $49.68 expiring on January 18, 2031, 17,000 at $17.63 expiring on March 28, 2032, 8,000 at $17.63 expiring on May 16, 2032, and 55,000 at $11.52 expiring on May 23, 2033. The 2021 grant is fully vested, while the 2022 and 2023 grants vest in 16 equal quarterly installments.
Positive
- None.
Negative
- None.
Insider Trade Summary
6 transactions reported
Mixed
6 txns
Insider
Aharon Cohen Tamar
Role
EVP & Chief Marketing Officer
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| holding | Stock Option (right to buy ordinary shares) | -- | -- | -- |
| holding | Stock Option (right to buy ordinary shares) | -- | -- | -- |
| holding | Stock Option (right to buy ordinary shares) | -- | -- | -- |
| holding | Stock Option (right to buy ordinary shares) | -- | -- | -- |
| holding | Ordinary shares | -- | -- | -- |
| holding | Ordinary shares | -- | -- | -- |
Holdings After Transaction:
Stock Option (right to buy ordinary shares) — 113,000 shares (Direct);
Ordinary shares — 59,474 shares (Direct)
Footnotes (5)
- F1. The ordinary shares reported in this row consist of shares underlying restricted share units that were granted to the Reporting Person on February 5, 2026, of which 50% vest on the 12-month anniversary of the grant date and the remaining 50% vest on the 24-month anniversary of the grant date.
- F2. The options reported in this row were granted to the Reporting Person by the Issuer on January 18, 2021 and are fully vested and exercisable as of the date of this report.
- F3. The options reported in this row were granted to the Reporting Person by the Issuer on March 28, 2022 and vest and become exercisable in 16 equal quarterly installments of 6.25% each on each three-month anniversary of the grant date, such that all options reported in this row will be exercisable on the four-year anniversary of the grant date (March 28, 2026).
- F4. The options reported in this row were granted to the Reporting Person by the Issuer on May 16, 2022 and vest and become exercisable in 16 equal quarterly installments of 6.25% each on each three-month anniversary of the grant date, such that all options reported in this row will be exercisable on the four-year anniversary of the grant date (May 16, 2026).
- F5. The options reported in this row were granted to the Reporting Person by the Issuer on May 23, 2023 and vest and become exercisable in 16 equal quarterly installments of 6.25% each on each three-month anniversary of the grant date, such that all options reported in this row will be exercisable on the four-year anniversary of the grant date (May 23, 2027).
AI-generated analysis. How Rhea-AI works. Not financial advice.
FAQ
What does the Nano-X (NNOX) Form 3 filing for Aharon Cohen Tamar show?
The Form 3 shows EVP & Chief Marketing Officer Aharon Cohen Tamar’s initial ownership. He holds ordinary shares, restricted share units granted on February 5, 2026, and multiple stock option grants with different exercise prices and expiration dates, all reported as directly owned positions.
What are the vesting terms of Aharon Cohen Tamar’s Nano-X (NNOX) option grants?
The January 18, 2021 option grant is fully vested and exercisable. The March 28, 2022, May 16, 2022, and May 23, 2023 grants vest in 16 equal quarterly installments of 6.25% each, becoming fully exercisable on the four‑year anniversaries of their respective grant dates.
Is Aharon Cohen Tamar’s Nano-X (NNOX) Form 3 a record of trades or holdings?
This Form 3 functions as an initial statement of beneficial ownership. The entries are categorized as holdings, with no buy or sell transactions reported, listing his existing ordinary shares, restricted share units, and stock option positions with their key terms.